Neoantigen DNA Vaccines Are Safe, Feasible, and Induce Neoantigen-Specific Immune Responses in Triple-Negative Breast Cancer Patients
Xiuli Zhang,S. Peter Goedegebuure,Michael Y. Chen,Rashmi Mishra,Felicia Zhang,Yik Yeung Yu,Kartik Singhal,Lijin Li,Feng Gao,Nancy B. Myers,Tammi Vickery,Jasreet Hundal,Michael D. McLellan,Mark A. Sturmoski,Samuel W. Kim,Ina Chen,Jesse T. Davidson,Narendra V. Sankpal,Stephanie Myles,Rama Suresh,Cynthia X. Ma,Ademuyiwa Foluso,Andrea Wang-Gillam,Sherri Davies,Ian S. Hagemann,Elaine R. Mardis,Obi Griffith,Malachi Griffith,Christopher A. Miller,Ted H. Hansen,Timothy P. Fleming,Robert D. Schreiber,William E. Gillanders
